These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25003907)

  • 1. [Novel drugs for COPD treatment].
    Gillissen A
    Pneumologie; 2014 Sep; 68(9):594-8. PubMed ID: 25003907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching treatments in COPD: implications for costs and treatment adherence.
    Braido F; Lavorini F; Blasi F; Baiardini I; Canonica GW
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2601-8. PubMed ID: 26664108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple inhalers for obstructive airways disease: will they be useful?
    Barnes PJ
    Expert Rev Respir Med; 2011 Jun; 5(3):297-300. PubMed ID: 21702649
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
    Cave AC; Hurst MM
    Pharmacol Ther; 2011 May; 130(2):114-43. PubMed ID: 21276815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in COPD disease management with fixed-dose long-acting combination therapies.
    Bateman ED; Mahler DA; Vogelmeier CF; Wedzicha JA; Patalano F; Banerji D
    Expert Rev Respir Med; 2014 Jun; 8(3):357-79. PubMed ID: 24802656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-year dispensing patterns with long-acting inhaled drugs in COPD: a database analysis.
    Penning-van Beest F; van Herk-Sukel M; Gale R; Lammers JW; Herings R
    Respir Med; 2011 Feb; 105(2):259-65. PubMed ID: 20705441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Triple fix-dose combination for treatment of COPD: convenient and effective].
    Worth H; Criée CP
    Dtsch Med Wochenschr; 2016 Nov; 141(23):1668. PubMed ID: 27855451
    [No Abstract]   [Full Text] [Related]  

  • 8. A pragmatic approach to simplify inhaler therapy for COPD.
    Lipworth B; Jabbal S
    Lancet Respir Med; 2017 Sep; 5(9):679-681. PubMed ID: 28693987
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximal bronchodilation: a therapeutic target in COPD?
    Agustí A; Dekhuijzen PR
    Lancet Respir Med; 2017 Jul; 5(7):540-542. PubMed ID: 28664854
    [No Abstract]   [Full Text] [Related]  

  • 11. Triple therapy for chronic obstructive pulmonary disease: trials catching up with clinical practice?
    Jones PW
    Am J Respir Crit Care Med; 2009 Oct; 180(8):689-90. PubMed ID: 19805796
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of corticosteroids in chronic obstructive pulmonary disease.
    Calverley PM
    Semin Respir Crit Care Med; 2005 Apr; 26(2):235-45. PubMed ID: 16088440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?
    Salama RO; Young PM; Rogueda P; Lallement A; Iliev I; Traini D
    Expert Opin Pharmacother; 2011 Aug; 12(12):1913-32. PubMed ID: 21714776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical treatment of COPD].
    Vestbo J; Titlestad IL
    Ugeskr Laeger; 2013 Apr; 175(18):1261-4. PubMed ID: 23651802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
    Joos GF
    Expert Opin Investig Drugs; 2010 Feb; 19(2):257-64. PubMed ID: 20047505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD.
    Prakash A; Babu KS; Morjaria JB
    Int J Chron Obstruct Pulmon Dis; 2015; 10():111-23. PubMed ID: 25609944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of inhaled corticosteroids in the management of COPD].
    Chazan R
    Pneumonol Alergol Pol; 2009; 77(2):186-91. PubMed ID: 19462354
    [No Abstract]   [Full Text] [Related]  

  • 19. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A; Gessner C; Hoheisel G; Juergens U
    Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Too many options, too little choice in COPD?
    Drug Ther Bull; 2016 Feb; 54(2):13. PubMed ID: 26848017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.